Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ZARNESTRA, tipifarnib, R115777
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.